Maja Beus - Search Results

Year	Number of Results
2018	3
2019	3
2020	2
2021	2
2022	3
2023	2
2024	1

1

Primaquine derivatives: Modifications of the terminal amino group.

Zorc B, Perković I, Pavić K, Rajić Z, Beus M. Zorc B, et al. Among authors: beus m. Eur J Med Chem. 2019 Nov 15;182:111640. doi: 10.1016/j.ejmech.2019.111640. Epub 2019 Aug 23. Eur J Med Chem. 2019. PMID: 31472472 Free PMC article. Review.

2

Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity.

Drinković N, Beus M, Barbir R, Debeljak Ž, Tariba Lovaković B, Kalčec N, Ćurlin M, Bekavac A, Gorup D, Mamić I, Mandić D, Micek V, Turčić P, Günday-Türeli N, Türeli E, Vinković Vrček I. Drinković N, et al. Among authors: beus m. Nanoscale. 2024 Apr 23. doi: 10.1039/d3nr06269d. Online ahead of print. Nanoscale. 2024. PMID: 38650478

3

Itaconic acid hybrids as potential anticancer agents.

Perković I, Beus M, Schols D, Persoons L, Zorc B. Perković I, et al. Among authors: beus m. Mol Divers. 2022 Feb;26(1):1-14. doi: 10.1007/s11030-020-10147-6. Epub 2020 Oct 11. Mol Divers. 2022. PMID: 33043404 Free PMC article.

4

Chloroquine fumardiamides as novel quorum sensing inhibitors.

Beus M, Savijoki K, Patel JZ, Yli-Kauhaluoma J, Fallarero A, Zorc B. Beus M, et al. Bioorg Med Chem Lett. 2020 Aug 15;30(16):127336. doi: 10.1016/j.bmcl.2020.127336. Epub 2020 Jun 9. Bioorg Med Chem Lett. 2020. PMID: 32631537

5

Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides.

Beus M, Fontinha D, Held J, Rajić Z, Prudêncio M, Zorc B. Beus M, et al. Acta Pharm. 2019 Jun 1;69(2):233-248. doi: 10.2478/acph-2019-0019. Acta Pharm. 2019. PMID: 31259728 Free article.

6

Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents.

Beus M, Fontinha D, Held J, Rajić Z, Uzelac L, Kralj M, Prudêncio M, Zorc B. Beus M, et al. Molecules. 2019 Aug 1;24(15):2812. doi: 10.3390/molecules24152812. Molecules. 2019. PMID: 31374989 Free PMC article.

7

Anthranilamides with quinoline and β-carboline scaffolds: design, synthesis, and biological activity.

Beus M, Persoons L, Daelemans D, Schols D, Savijoki K, Varmanen P, Yli-Kauhaluoma J, Pavić K, Zorc B. Beus M, et al. Mol Divers. 2022 Oct;26(5):2595-2612. doi: 10.1007/s11030-021-10347-8. Epub 2022 Jan 8. Mol Divers. 2022. PMID: 34997441 Free PMC article.

8

Synthesis and Biological Evaluation of New Quinoline and Anthranilic Acid Derivatives as Potential Quorum Sensing Inhibitors.

Perković I, Poljak T, Savijoki K, Varmanen P, Maravić-Vlahoviček G, Beus M, Kučević A, Džajić I, Rajić Z. Perković I, et al. Among authors: beus m. Molecules. 2023 Aug 3;28(15):5866. doi: 10.3390/molecules28155866. Molecules. 2023. PMID: 37570836 Free PMC article.

9

Mass spectrometry imaging in zebrafish larvae for assessing drug safety and metabolism.

Asslan M, Lauzon N, Beus M, Maysinger D, Rousseau S. Asslan M, et al. Among authors: beus m. Anal Bioanal Chem. 2021 Aug;413(20):5135-5146. doi: 10.1007/s00216-021-03476-4. Epub 2021 Jun 26. Anal Bioanal Chem. 2021. PMID: 34173039

10

Particle surface functionalization affects mechanism of endocytosis and adverse effects of silver nanoparticles in mammalian kidney cells.

Beus M, Pongrac IM, Capjak I, Ilić K, Vrček E, Ćurlin M, Milić M, Čermak AMM, Pavičić I. Beus M, et al. J Appl Toxicol. 2023 Mar;43(3):416-430. doi: 10.1002/jat.4392. Epub 2022 Sep 13. J Appl Toxicol. 2023. PMID: 36065485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year